| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | lyase activity | 1.52e-05 | 212 | 104 | 8 | GO:0016829 | |
| GeneOntologyMolecularFunction | palmitoyl-CoA 9-desaturase activity | 2.69e-05 | 2 | 104 | 2 | GO:0032896 | |
| GeneOntologyMolecularFunction | carbonate dehydratase activity | 7.32e-05 | 16 | 104 | 3 | GO:0004089 | |
| GeneOntologyMolecularFunction | transition metal ion binding | PAPPA2 NAALADL1 ADAMTS3 CYP11A1 CA13 MMP21 PGLYRP2 CHD4 SCD5 L3MBTL1 SYTL4 PIM1 SCD ZFHX3 CA2 CA3 DNMT1 | 1.33e-04 | 1189 | 104 | 17 | GO:0046914 |
| GeneOntologyMolecularFunction | stearoyl-CoA 9-desaturase activity | 1.60e-04 | 4 | 104 | 2 | GO:0004768 | |
| GeneOntologyMolecularFunction | NAD transmembrane transporter activity | 2.66e-04 | 5 | 104 | 2 | GO:0051724 | |
| GeneOntologyMolecularFunction | acyl-CoA desaturase activity | 2.66e-04 | 5 | 104 | 2 | GO:0016215 | |
| GeneOntologyMolecularFunction | hydro-lyase activity | 3.27e-04 | 63 | 104 | 4 | GO:0016836 | |
| GeneOntologyMolecularFunction | zinc ion binding | PAPPA2 NAALADL1 ADAMTS3 CA13 MMP21 PGLYRP2 CHD4 L3MBTL1 SYTL4 ZFHX3 CA2 CA3 DNMT1 | 7.29e-04 | 891 | 104 | 13 | GO:0008270 |
| GeneOntologyMolecularFunction | carbon-oxygen lyase activity | 8.89e-04 | 82 | 104 | 4 | GO:0016835 | |
| GeneOntologyBiologicalProcess | mitochondrial NAD transmembrane transport | 2.47e-05 | 2 | 103 | 2 | GO:1990549 | |
| GeneOntologyBiologicalProcess | monounsaturated fatty acid biosynthetic process | 2.47e-05 | 2 | 103 | 2 | GO:1903966 | |
| GeneOntologyBiologicalProcess | tarsal gland development | 7.38e-05 | 3 | 103 | 2 | GO:1903699 | |
| GeneOntologyBiologicalProcess | monounsaturated fatty acid metabolic process | 7.38e-05 | 3 | 103 | 2 | GO:1903964 | |
| GeneOntologyCellularComponent | apical part of cell | PAPPA2 NAALADL1 HIP1R CDH23 SLC3A1 ITPR3 DUOX1 SLC9A3 SYTL4 SLC5A6 CNTFR CA2 | 4.65e-05 | 592 | 106 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | PAPPA2 NAALADL1 HIP1R SLC3A1 ITPR3 DUOX1 SLC9A3 SYTL4 SLC5A6 CNTFR | 1.86e-04 | 487 | 106 | 10 | GO:0016324 |
| Domain | Acyl-CoA_DS | 3.13e-05 | 2 | 105 | 2 | IPR015876 | |
| Domain | FATTY_ACID_DESATUR_1 | 3.13e-05 | 2 | 105 | 2 | PS00476 | |
| Domain | FADS-1_CS | 3.13e-05 | 2 | 105 | 2 | IPR001522 | |
| Domain | CA2 | 3.13e-05 | 2 | 105 | 2 | IPR018443 | |
| Domain | Carbonic_anhydrase_a-class_CS | 3.66e-05 | 12 | 105 | 3 | IPR018338 | |
| Domain | Carbonic_anhydrase_a-class | 7.48e-05 | 15 | 105 | 3 | IPR023561 | |
| Domain | ALPHA_CA_1 | 7.48e-05 | 15 | 105 | 3 | PS00162 | |
| Domain | Carb_anhydrase | 1.11e-04 | 17 | 105 | 3 | PF00194 | |
| Domain | Carb_anhydrase | 1.11e-04 | 17 | 105 | 3 | SM01057 | |
| Domain | - | 1.11e-04 | 17 | 105 | 3 | 3.10.200.10 | |
| Domain | ALPHA_CA_2 | 1.11e-04 | 17 | 105 | 3 | PS51144 | |
| Domain | Carbonic_anhydrase_a | 1.11e-04 | 17 | 105 | 3 | IPR001148 | |
| Domain | CEBP_ZZ | 1.86e-04 | 4 | 105 | 2 | PF16366 | |
| Domain | RRM_7 | 1.86e-04 | 4 | 105 | 2 | PF16367 | |
| Domain | CEBP_ZZ | 1.86e-04 | 4 | 105 | 2 | IPR032296 | |
| Domain | GST_C | 4.09e-04 | 26 | 105 | 3 | IPR004046 | |
| Domain | GST_C | 4.09e-04 | 26 | 105 | 3 | PF00043 | |
| Domain | Glutathione_S-Trfase_N | 4.58e-04 | 27 | 105 | 3 | IPR004045 | |
| Domain | FA_desaturase_dom | 8.57e-04 | 8 | 105 | 2 | IPR005804 | |
| Domain | FA_desaturase | 8.57e-04 | 8 | 105 | 2 | PF00487 | |
| Domain | GPS | 9.10e-04 | 34 | 105 | 3 | SM00303 | |
| Domain | GST_CTER | 9.10e-04 | 34 | 105 | 3 | PS50405 | |
| Domain | GPS | 9.91e-04 | 35 | 105 | 3 | PF01825 | |
| Domain | GPS | 1.08e-03 | 36 | 105 | 3 | PS50221 | |
| Domain | GPS | 1.17e-03 | 37 | 105 | 3 | IPR000203 | |
| Domain | Glutathione-S-Trfase_C-like | 1.36e-03 | 39 | 105 | 3 | IPR010987 | |
| Domain | - | 1.36e-03 | 39 | 105 | 3 | 1.20.1050.10 | |
| Domain | FYVE_2 | 1.67e-03 | 11 | 105 | 2 | PF02318 | |
| Domain | XK-related | 1.67e-03 | 11 | 105 | 2 | PF09815 | |
| Domain | XK_rel | 1.67e-03 | 11 | 105 | 2 | IPR018629 | |
| Domain | RABBD | 1.99e-03 | 12 | 105 | 2 | PS50916 | |
| Domain | Rab_BD | 1.99e-03 | 12 | 105 | 2 | IPR010911 | |
| Domain | 7tm_2 | 2.79e-03 | 50 | 105 | 3 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.79e-03 | 50 | 105 | 3 | PS00650 | |
| Domain | A/G_cyclase_CS | 4.03e-03 | 17 | 105 | 2 | IPR018297 | |
| Domain | - | 4.52e-03 | 18 | 105 | 2 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 4.52e-03 | 18 | 105 | 2 | IPR029787 | |
| Domain | GPCR_2_secretin-like | 4.68e-03 | 60 | 105 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.68e-03 | 60 | 105 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.91e-03 | 61 | 105 | 3 | PS50261 | |
| Domain | Guanylate_cyc | 5.03e-03 | 19 | 105 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 5.03e-03 | 19 | 105 | 2 | PS50125 | |
| Domain | A/G_cyclase | 5.03e-03 | 19 | 105 | 2 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 5.03e-03 | 19 | 105 | 2 | PS00452 | |
| Domain | CYCc | 5.03e-03 | 19 | 105 | 2 | SM00044 | |
| Domain | TSP_1 | 5.37e-03 | 63 | 105 | 3 | PF00090 | |
| Pathway | REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE | 4.02e-05 | 12 | 82 | 3 | M671 | |
| Pathway | WP_ELONGATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS | 4.02e-05 | 12 | 82 | 3 | MM17077 | |
| Pathway | REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE | 4.02e-05 | 12 | 82 | 3 | MM14574 | |
| Pathway | WP_OMEGA9_FATTY_ACID_SYNTHESIS | 6.59e-05 | 14 | 82 | 3 | M39780 | |
| Pathway | KEGG_NITROGEN_METABOLISM | 3.09e-04 | 23 | 82 | 3 | M4629 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 3.09e-04 | 23 | 82 | 3 | MM15885 | |
| Pubmed | 2.83e-08 | 3 | 107 | 3 | 32961871 | ||
| Pubmed | 1.13e-07 | 4 | 107 | 3 | 23727646 | ||
| Pubmed | 2.82e-07 | 5 | 107 | 3 | 18079124 | ||
| Pubmed | MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1. | 5.62e-07 | 6 | 107 | 3 | 32035613 | |
| Pubmed | 1.57e-06 | 8 | 107 | 3 | 20820888 | ||
| Pubmed | 2.35e-06 | 9 | 107 | 3 | 23637738 | ||
| Pubmed | 3.23e-06 | 33 | 107 | 4 | 27416896 | ||
| Pubmed | 3.34e-06 | 10 | 107 | 3 | 12588883 | ||
| Pubmed | 4.59e-06 | 11 | 107 | 3 | 24789143 | ||
| Pubmed | Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. | 4.59e-06 | 11 | 107 | 3 | 14668353 | |
| Pubmed | MED1 is a lipogenesis coactivator required for postnatal adipose expansion. | 4.59e-06 | 11 | 107 | 3 | 33888555 | |
| Pubmed | A systematic quantification of carbonic anhydrase transcripts in the mouse digestive system. | 6.10e-06 | 12 | 107 | 3 | 17362527 | |
| Pubmed | 6.10e-06 | 12 | 107 | 3 | 27307439 | ||
| Pubmed | 7.92e-06 | 13 | 107 | 3 | 7803821 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17391062 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 29965978 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 36124130 | ||
| Pubmed | [Role of stearoyl-CoA desaturase in regulation of energy metabolism]. | 9.38e-06 | 2 | 107 | 2 | 18788462 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 16801925 | ||
| Pubmed | Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. | 9.38e-06 | 2 | 107 | 2 | 10545940 | |
| Pubmed | Metabolic changes in skin caused by Scd1 deficiency: a focus on retinol metabolism. | 9.38e-06 | 2 | 107 | 2 | 21573029 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15610069 | ||
| Pubmed | Characterization of HSCD5, a novel human stearoyl-CoA desaturase unique to primates. | 9.38e-06 | 2 | 107 | 2 | 15907797 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 9689914 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22539624 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19910642 | ||
| Pubmed | The expression of the gene asebia in the laboratory mouse. I. Epidermis and dermis. | 9.38e-06 | 2 | 107 | 2 | 631559 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 35718096 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 5924301 | ||
| Pubmed | SCD1 promotes lipid mobilization in subcutaneous white adipose tissue. | 9.38e-06 | 2 | 107 | 2 | 32978274 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12960377 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 16829692 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 9854036 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12364560 | ||
| Pubmed | Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. | 9.38e-06 | 2 | 107 | 2 | 17127673 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 11441127 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 20923962 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 25959085 | ||
| Pubmed | Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy. | 9.38e-06 | 2 | 107 | 2 | 33690217 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23221600 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 29326439 | ||
| Pubmed | Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. | 9.38e-06 | 2 | 107 | 2 | 10484602 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22431519 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12401889 | ||
| Pubmed | Scd3--a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. | 9.38e-06 | 2 | 107 | 2 | 11161812 | |
| Pubmed | Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. | 9.38e-06 | 2 | 107 | 2 | 8790349 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 35341816 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12454277 | ||
| Pubmed | Stearoyl-CoA desaturase 1 activity is required for autophagosome formation. | 9.38e-06 | 2 | 107 | 2 | 25023287 | |
| Pubmed | Combined deletion of SCD1 from adipose tissue and liver does not protect mice from obesity. | 9.38e-06 | 2 | 107 | 2 | 22669918 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15494611 | ||
| Pubmed | Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease. | 9.38e-06 | 2 | 107 | 2 | 22046234 | |
| Pubmed | Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. | 9.38e-06 | 2 | 107 | 2 | 12177411 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 18832746 | ||
| Pubmed | Stearoyl-CoA desaturase 1 deficiency protects mice from immune-mediated liver injury. | 9.38e-06 | 2 | 107 | 2 | 19002112 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 25675381 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 11533264 | ||
| Pubmed | Glycerol regulates stratum corneum hydration in sebaceous gland deficient (asebia) mice. | 9.38e-06 | 2 | 107 | 2 | 12713573 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 18054317 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 16275639 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 12419843 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 15210843 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 18381840 | ||
| Pubmed | Identification of a novel SCD gene and expression of the SCD gene family in mouse skin. | 9.38e-06 | 2 | 107 | 2 | 10674390 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 30118512 | ||
| Pubmed | Asebia-2J (Scd1(ab2J)): a new allele and a model for scarring alopecia. | 9.38e-06 | 2 | 107 | 2 | 10854228 | |
| Pubmed | Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice. | 9.38e-06 | 2 | 107 | 2 | 15340109 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 18042664 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21658928 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 26041446 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 17033839 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8541340 | ||
| Pubmed | Polyunsaturated fatty acids do not activate AMP-activated protein kinase in mouse tissues. | 9.38e-06 | 2 | 107 | 2 | 15916750 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 23747827 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 33374300 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 28659287 | ||
| Pubmed | Polyunsaturated fatty acids inhibit hepatic stearoyl-CoA desaturase-1 gene in diabetic mice. | 9.38e-06 | 2 | 107 | 2 | 8729090 | |
| Pubmed | Identification and characterization of GSTT3, a third murine Theta class glutathione transferase. | 9.38e-06 | 2 | 107 | 2 | 12038961 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 25130896 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 22101133 | ||
| Pubmed | Compartmentalization of stearoyl-coenzyme A desaturase 1 activity in HepG2 cells. | 9.38e-06 | 2 | 107 | 2 | 18599738 | |
| Pubmed | Structure and Mechanism of a Unique Diiron Center in Mammalian Stearoyl-CoA Desaturase. | 9.38e-06 | 2 | 107 | 2 | 32470559 | |
| Pubmed | Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism. | 9.38e-06 | 2 | 107 | 2 | 23941875 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 30930246 | ||
| Pubmed | Dietary regulation of stearoyl-CoA desaturase 1 gene expression in mouse liver. | 9.38e-06 | 2 | 107 | 2 | 1350282 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 19424424 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 28143772 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 14579408 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 10899171 | ||
| Pubmed | Susceptibility of podocytes to palmitic acid is regulated by stearoyl-CoA desaturases 1 and 2. | 9.38e-06 | 2 | 107 | 2 | 23867797 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 18249173 | ||
| Pubmed | Differential expression of hepatic stearoyl-CoA desaturase gene 1 in male and female mice. | 9.38e-06 | 2 | 107 | 2 | 8954132 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 24088802 | ||
| Pubmed | Hepatic oleate regulates adipose tissue lipogenesis and fatty acid oxidation. | 9.38e-06 | 2 | 107 | 2 | 25555387 | |
| Pubmed | Stearoyl CoA desaturase is required to produce active, lipid-modified Wnt proteins. | 9.38e-06 | 2 | 107 | 2 | 24055053 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 27834856 | ||
| Pubmed | Mammalian class theta GST and differential susceptibility to carcinogens: a review. | 9.38e-06 | 2 | 107 | 2 | 11018744 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8617493 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 26976120 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 37054998 | ||
| GeneFamily | Carbonic anhydrases | 6.25e-05 | 18 | 79 | 3 | 460 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.72e-04 | 25 | 79 | 3 | 504 | |
| GeneFamily | Fatty acid desaturases | 5.19e-04 | 8 | 79 | 2 | 553 | |
| GeneFamily | Synaptotagmin like tandem C2 proteins | 8.29e-04 | 10 | 79 | 2 | 822 | |
| GeneFamily | Blood group antigens|XK related family | 1.01e-03 | 11 | 79 | 2 | 955 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.91e-03 | 15 | 79 | 2 | 529 | |
| GeneFamily | Ankyrin repeat domain containing | 4.16e-03 | 242 | 79 | 5 | 403 | |
| GeneFamily | Glutathione S-transferases | 5.30e-03 | 25 | 79 | 2 | 567 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | ABHD18 PILRB CDH23 ADGRG1 GAL3ST4 PPP1R15A ADCY7 ITPR3 MOGS SBF1 FKTN TTC31 SGSM2 DAPP1 DENND6B ZFHX3 DNMT1 | 1.53e-07 | 905 | 107 | 17 | M40865 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | ABHD18 PILRB CDH23 PPP1R15A ADCY7 ITPR3 MOGS TTC31 SGSM2 DAPP1 ZFHX3 DNMT1 | 1.11e-05 | 634 | 107 | 12 | M40866 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-08 | 196 | 107 | 8 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | ASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.53e-08 | 196 | 107 | 8 | 754b4202b617165c6994a0b5a9b1e486dccdd44d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-08 | 197 | 107 | 8 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.85e-08 | 199 | 107 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.85e-08 | 150 | 107 | 7 | 42fd42a0be918a77aca4e0c91f068bdd5a5d9286 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.85e-08 | 150 | 107 | 7 | 954ca50b36dadaab625ab011aedbf550de2e566f | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.85e-08 | 150 | 107 | 7 | c2fcdd62ec85cbf9783a525cd7556e16a1e55cd8 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-07 | 187 | 107 | 7 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | ASK440-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.00e-07 | 197 | 107 | 7 | 08d5bbeb77a4152af1c783bc958afcae24667767 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.17e-07 | 198 | 107 | 7 | 19eefd05573fbaed654af52bf0f8a26092b8b229 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.14e-07 | 126 | 107 | 6 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.22e-06 | 157 | 107 | 6 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.72e-06 | 179 | 107 | 6 | 466da2bc3bfc534ffe111c8c28ece7a3cfa08051 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.72e-06 | 179 | 107 | 6 | f4bdebb77d39e63160fbf3a85a340ce4d52b7cfd | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 181 | 107 | 6 | 35eefd874a892eaf21f24fdce89e7ea3b8ee285f | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 181 | 107 | 6 | e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-06 | 182 | 107 | 6 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-06 | 182 | 107 | 6 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-06 | 184 | 107 | 6 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.53e-06 | 184 | 107 | 6 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-06 | 184 | 107 | 6 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.71e-06 | 185 | 107 | 6 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.71e-06 | 185 | 107 | 6 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-06 | 189 | 107 | 6 | da014519d6eb21bc2dc2ed65eafe638b42a068ed | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.45e-06 | 189 | 107 | 6 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.27e-06 | 193 | 107 | 6 | 8646e573f2d2ff175f3d02bfdf214e65f3b614d3 | |
| ToppCell | (7)_Epithelial_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.49e-06 | 194 | 107 | 6 | 413e8b9f1e15be363a7f4a8f727af3eeb9e9a928 | |
| ToppCell | AT2|World / shred by cell class for parenchyma | 7.49e-06 | 194 | 107 | 6 | e773f5ef3abce7113a6b7cc7cbe68de873d4a17f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.71e-06 | 195 | 107 | 6 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT2-AT2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.71e-06 | 195 | 107 | 6 | 6867f9c56ea27a17c8c4099aae0d79903c3748a5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.71e-06 | 195 | 107 | 6 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-C_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.71e-06 | 195 | 107 | 6 | d0608db4a61576e67f4a3a52e1f84d788a1dea85 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-C_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.71e-06 | 195 | 107 | 6 | bdfe486d32cb598950c1a5f5cdab40302c8f0f99 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.71e-06 | 195 | 107 | 6 | 3e24570def013d5b0b1ef1d7a5ced7dfd922590b | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.71e-06 | 195 | 107 | 6 | 955a0a7244cd7eaf006a39e1bd03333baf6f30a4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.71e-06 | 195 | 107 | 6 | eec187c087e432417bc346c5d3ead72f58bf3215 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 196 | 107 | 6 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-06 | 196 | 107 | 6 | b1abecc0aafc09ca70a5fde624f2a998c4aa3341 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.94e-06 | 196 | 107 | 6 | a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.17e-06 | 197 | 107 | 6 | f3ca63c7902d7530a29a85eb54f69b303031d150 | |
| ToppCell | 390C-Epithelial_cells|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.17e-06 | 197 | 107 | 6 | 78554b26b04752e7cd80402c93a3a491560e8f5f | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.17e-06 | 197 | 107 | 6 | f98720cab066579fdac3ba24fb6fe4c5759dae4e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 198 | 107 | 6 | 43a2ce64fa309bac89a44ea320e87ae2cc39f782 | |
| ToppCell | ASK428-Epithelial-Type_2|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.41e-06 | 198 | 107 | 6 | ec0d1801363adb70c6a26655b79d12b438c7417d | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.66e-06 | 199 | 107 | 6 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-06 | 199 | 107 | 6 | 7ebd89dff457f57a549eecee288c7a4b515b4018 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-06 | 199 | 107 | 6 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-06 | 199 | 107 | 6 | fa5ddba3ac1ebe712cd4cdc3f20339f7c715d039 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.66e-06 | 199 | 107 | 6 | 5323d49d3be980605b3e609b7f03bddba6e50e8a | |
| ToppCell | Biopsy_IPF-Epithelial-AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 8.66e-06 | 199 | 107 | 6 | c841d475703d3489161fb7904526bd7563d5fb0f | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.91e-06 | 200 | 107 | 6 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.91e-06 | 200 | 107 | 6 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.91e-06 | 200 | 107 | 6 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-05 | 130 | 107 | 5 | 3709d17044d48b120effd8ba4104ca81c49d7e19 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.95e-05 | 136 | 107 | 5 | e3a2425ba5ef538dbacab1479e682837ae42a888 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.53e-05 | 154 | 107 | 5 | a2adaa4a6cd8708cd579b8efbeb4ff2131c5482e | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 160 | 107 | 5 | 237430af14830b38e58da8a4224036e5c6b71c5b | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.50e-05 | 162 | 107 | 5 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.50e-05 | 162 | 107 | 5 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 164 | 107 | 5 | 90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 172 | 107 | 5 | 3ffe721f62c0d20c1d765ecb15ed4e1aa88099f7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 172 | 107 | 5 | 2bbe3f601a56577d200aa7ba7031f7c19b988cc1 | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 5.98e-05 | 172 | 107 | 5 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.31e-05 | 174 | 107 | 5 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.31e-05 | 174 | 107 | 5 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | droplet-Heart-nan-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 174 | 107 | 5 | cf4e0567f2a4ebe5534046b1c091af59b55bdc4f | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.31e-05 | 174 | 107 | 5 | b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.84e-05 | 177 | 107 | 5 | 41cbb2c109eaa7be366fc0510cce64abc06837b4 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.84e-05 | 177 | 107 | 5 | c1f838e425ebb04482829b1957e3c1347127e6de | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.03e-05 | 178 | 107 | 5 | b902059c3f861108fc64cbdc05e6f44378f5be2c | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 7.41e-05 | 180 | 107 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 180 | 107 | 5 | 41e8155cc7b3dac9d496e4077845ca6af1591a5c | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 7.61e-05 | 181 | 107 | 5 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.81e-05 | 182 | 107 | 5 | 0e52ba34e179d9bfaac7b49920b44c710b2b8dad | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.81e-05 | 182 | 107 | 5 | c6172aca2475bf0948a78e39f0dae6388504a915 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-05 | 182 | 107 | 5 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-05 | 182 | 107 | 5 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-05 | 182 | 107 | 5 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-05 | 182 | 107 | 5 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.01e-05 | 183 | 107 | 5 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.15e-05 | 95 | 107 | 4 | 3d6b97576ce4e7a3e495cbc7246ea8c0b2a386f7 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.43e-05 | 185 | 107 | 5 | 7b1c5d99bd7a6e148524029758cee244a17f5d09 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.43e-05 | 185 | 107 | 5 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.43e-05 | 185 | 107 | 5 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.43e-05 | 185 | 107 | 5 | e9033a03d574956cf3ae228740b3166e40a6397f | |
| ToppCell | AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.43e-05 | 185 | 107 | 5 | 3b3268e3f99121124e33086cac88479808d31630 | |
| ToppCell | PND01-03-samps-Epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.43e-05 | 185 | 107 | 5 | 2b854df79cfe2cb4d2f9c2938a066e0aa3649325 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.43e-05 | 185 | 107 | 5 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.43e-05 | 185 | 107 | 5 | 578f12c6b2e33d09598dc8e022a20c8555d1325c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-05 | 186 | 107 | 5 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.87e-05 | 187 | 107 | 5 | 11670a85db87cbb3e78022a589632173604b0940 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 8.87e-05 | 187 | 107 | 5 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.87e-05 | 187 | 107 | 5 | 23fe3cdd6cc9b067086a8392d104186d300298ea | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.87e-05 | 187 | 107 | 5 | 0277d4e54bd4d48f30241c2951a569209423fee8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.09e-05 | 188 | 107 | 5 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.09e-05 | 188 | 107 | 5 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 9.09e-05 | 188 | 107 | 5 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.09e-05 | 188 | 107 | 5 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.32e-05 | 189 | 107 | 5 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | Control-Myeloid-MoAM1|Control / Disease group,lineage and cell class (2021.01.30) | 9.32e-05 | 189 | 107 | 5 | 55d5c2fb9e6ab556d42c83a1e985ee66e4cf9dba | |
| Drug | AC1L9LQQ | 2.64e-07 | 57 | 106 | 6 | CID000448224 | |
| Drug | chlorzolamide | 3.07e-07 | 13 | 106 | 4 | CID000165323 | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 3.61e-07 | 197 | 106 | 9 | 5605_UP | |
| Drug | sterculic acid | 3.39e-06 | 7 | 106 | 3 | CID000012921 | |
| Drug | potassium cyanate | 4.39e-06 | 24 | 106 | 4 | CID011378442 | |
| Drug | aminozolamide | 5.40e-06 | 8 | 106 | 3 | CID000093505 | |
| Drug | L-662,583 | 5.40e-06 | 8 | 106 | 3 | CID003082977 | |
| Drug | L-643,799 | 5.40e-06 | 8 | 106 | 3 | CID000121595 | |
| Drug | sezolamide | 5.40e-06 | 8 | 106 | 3 | CID000060692 | |
| Drug | methazolamide | 6.13e-06 | 26 | 106 | 4 | CID000004100 | |
| Drug | 1gaf | 6.29e-06 | 56 | 106 | 5 | CID000444283 | |
| Drug | qassa | 8.07e-06 | 9 | 106 | 3 | CID003082191 | |
| Drug | 6-hydroxyethoxzolamide | 8.07e-06 | 9 | 106 | 3 | CID000094706 | |
| Drug | benzolamide | 8.34e-06 | 28 | 106 | 4 | CID000018794 | |
| Drug | AC1L1FF5 | 8.92e-06 | 157 | 106 | 7 | CID000003209 | |
| Drug | Prontosil | 1.15e-05 | 10 | 106 | 3 | CID000066895 | |
| Drug | metanilamide | 1.15e-05 | 10 | 106 | 3 | CID000007377 | |
| Drug | 1,3-benzenedisulfonamide | 1.15e-05 | 10 | 106 | 3 | CID003090044 | |
| Drug | carbamoyl phosphate | 1.49e-05 | 113 | 106 | 6 | CID000000278 | |
| Drug | Cl 13850 | 1.58e-05 | 11 | 106 | 3 | CID000159459 | |
| Drug | cobalt phosphate | 1.58e-05 | 11 | 106 | 3 | CID000061615 | |
| Drug | Tio-urasin | 1.58e-05 | 11 | 106 | 3 | CID000084724 | |
| Drug | hydroflumethiazide | 2.09e-05 | 12 | 106 | 3 | CID000003647 | |
| Drug | sulfamidochrysoidine | 2.15e-05 | 2 | 106 | 2 | ctd:C003359 | |
| Drug | dorzolamide | 2.15e-05 | 2 | 106 | 2 | ctd:C062765 | |
| Drug | chlorthalidone | 2.33e-05 | 36 | 106 | 4 | CID000002732 | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; PC3; HT_HG-U133A | 2.67e-05 | 186 | 106 | 7 | 3768_UP | |
| Drug | mafenide acetate | 2.71e-05 | 13 | 106 | 3 | CID000003998 | |
| Drug | Fg 400 | 2.71e-05 | 13 | 106 | 3 | CID000012443 | |
| Drug | cobalt;sulfide | 3.44e-05 | 14 | 106 | 3 | CID000159453 | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; PC3; HG-U133A | 3.74e-05 | 196 | 106 | 7 | 1923_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; PC3; HT_HG-U133A | 3.74e-05 | 196 | 106 | 7 | 3726_DN | |
| Drug | Amoxapine [14028-44-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.86e-05 | 197 | 106 | 7 | 1513_UP | |
| Drug | Flucytosine [2022-85-7]; Down 200; 31uM; PC3; HT_HG-U133A | 4.25e-05 | 200 | 106 | 7 | 6690_DN | |
| Drug | AC1L1F9Q | 4.39e-05 | 201 | 106 | 7 | CID000003144 | |
| Drug | ethacrynic acid | 4.61e-05 | 138 | 106 | 6 | CID000003278 | |
| Drug | Bicarbonates | 5.26e-05 | 16 | 106 | 3 | ctd:D001639 | |
| Drug | eicosa-8,11,14-trienoic acid | 5.73e-05 | 88 | 106 | 5 | CID000003011 | |
| Drug | metolazone | 6.36e-05 | 17 | 106 | 3 | CID000004170 | |
| Drug | Dichlorphenamide | 6.42e-05 | 3 | 106 | 2 | ctd:D004005 | |
| Drug | I2-15 | 6.42e-05 | 3 | 106 | 2 | CID000013388 | |
| Drug | Benzolamide | 6.42e-05 | 3 | 106 | 2 | ctd:D001574 | |
| Drug | Ethoxzolamide | 6.42e-05 | 3 | 106 | 2 | ctd:D005016 | |
| Drug | betaxolol | 7.38e-05 | 48 | 106 | 4 | CID000002369 | |
| Drug | apraclonidine | 7.61e-05 | 18 | 106 | 3 | CID000002216 | |
| Drug | 1-methylcyclopentanecarboxylic acid | 8.26e-05 | 95 | 106 | 5 | CID000138436 | |
| Drug | sulthiame | 9.00e-05 | 19 | 106 | 3 | CID000005356 | |
| Drug | racemic timolol | 9.37e-05 | 51 | 106 | 4 | CID000005478 | |
| Drug | indapamide | 1.09e-04 | 53 | 106 | 4 | CID000003702 | |
| Drug | oxygen | 1.14e-04 | 499 | 106 | 10 | CID000000977 | |
| Drug | AC1LCVB4 | 1.23e-04 | 21 | 106 | 3 | CID000656627 | |
| Drug | N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide | 1.28e-04 | 4 | 106 | 2 | ctd:C439829 | |
| Drug | D-GDH | 1.28e-04 | 4 | 106 | 2 | CID000128097 | |
| Drug | 9-hexadecenal | 1.28e-04 | 4 | 106 | 2 | CID000092066 | |
| Drug | I-7B | 1.28e-04 | 4 | 106 | 2 | CID000067136 | |
| Drug | AABSSN | 1.42e-04 | 22 | 106 | 3 | CID005464134 | |
| Drug | tiadenol | 1.45e-04 | 57 | 106 | 4 | CID000023403 | |
| Drug | dichlorphenamide | 1.62e-04 | 23 | 106 | 3 | CID000003038 | |
| Drug | 2,2,5,7,8-pentamethyl-1-hydroxychroman | 1.80e-04 | 252 | 106 | 7 | ctd:C029141 | |
| Drug | Fe(III | 2.06e-04 | 537 | 106 | 10 | CID000023925 | |
| Drug | pinolenic acid | 2.09e-04 | 25 | 106 | 3 | CID005312493 | |
| Drug | 1-penten-3-ol | 2.13e-04 | 5 | 106 | 2 | CID000012020 | |
| Drug | methyl sterculate | 2.13e-04 | 5 | 106 | 2 | CID000115261 | |
| Drug | 16-methylprogesterone | 2.13e-04 | 5 | 106 | 2 | CID000134874 | |
| Drug | brinzolamide | 2.13e-04 | 5 | 106 | 2 | ctd:C111827 | |
| Disease | Charcot-Marie-Tooth disease (biomarker_via_orthology) | 1.16e-05 | 2 | 101 | 2 | DOID:10595 (biomarker_via_orthology) | |
| Disease | carbonic anhydrase 1 measurement | 3.47e-05 | 3 | 101 | 2 | EFO_0020227 | |
| Disease | Prostatic Intraepithelial Neoplasias | 6.25e-04 | 11 | 101 | 2 | C0282612 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 6.40e-04 | 49 | 101 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | 3-formylindole measurement | 8.83e-04 | 13 | 101 | 2 | EFO_0801025 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 8.83e-04 | 13 | 101 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Premature atrial contractions | 8.97e-04 | 55 | 101 | 3 | HP_0006699 | |
| Disease | serum albumin measurement | 9.88e-04 | 592 | 101 | 8 | EFO_0004535 | |
| Disease | Pneumoconiosis | 1.03e-03 | 14 | 101 | 2 | C0032273 | |
| Disease | Bagassosis | 1.03e-03 | 14 | 101 | 2 | C0004681 | |
| Disease | intracerebral hemorrhage | 1.35e-03 | 16 | 101 | 2 | EFO_0005669 | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 1.53e-03 | 17 | 101 | 2 | DOID:11984 (is_marker_for) | |
| Disease | mean arterial pressure | 1.66e-03 | 499 | 101 | 7 | EFO_0006340 | |
| Disease | colorectal cancer (is_marker_for) | 2.11e-03 | 157 | 101 | 4 | DOID:9256 (is_marker_for) | |
| Disease | smoking status measurement, diastolic blood pressure | 2.21e-03 | 159 | 101 | 4 | EFO_0006336, EFO_0006527 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGEKALYHAGLFLWH | 106 | Q7Z4L5 | |
| LYHAGLFLWHIGRHD | 111 | Q7Z4L5 | |
| GPYRLRQFHLHWGSS | 86 | P07451 | |
| YVHLWEALGHHGRSR | 496 | Q8NAG6 | |
| YWGFRATDHHVQGRD | 126 | Q5T035 | |
| RHNHWAGLYGRLEWD | 1506 | P26358 | |
| HTHLLQFDGEGGWRF | 671 | Q9UBJ2 | |
| IHLAGTGDHHYWRRR | 111 | Q0P651 | |
| GRLGDLWDYHQHRYL | 211 | Q5T440 | |
| AHSNLNGVWYRGGHY | 446 | O95841 | |
| LHGHFNWTARAALLY | 156 | P20594 | |
| HKRGHFASVWQRSLY | 551 | Q12797 | |
| TGSYRLRQVHLHWGS | 86 | Q8N1Q1 | |
| WGAARPFAHLNHRES | 491 | P51828 | |
| DHHWASDRGLLSRPY | 786 | O14529 | |
| CGGQRSPWHADDRHY | 101 | Q8NEG7 | |
| RVWYRILHGNHGNNF | 1136 | Q9H251 | |
| EWRPVHYAAFHGRLG | 131 | Q8N9B4 | |
| GAGHWNGLYRFKHLA | 296 | Q14573 | |
| HRGVDGQWDLSNYHL | 1026 | O60271 | |
| RSFRGFWLTHHLYIL | 1216 | Q9NRD9 | |
| DNHHEWFRFSGRILG | 1301 | Q9P2P5 | |
| WRNNTEYRGGYHDNH | 1461 | Q9P2P5 | |
| YRLSGSFAHQGLWRY | 31 | P55344 | |
| AHCSGSRYWVRLGEH | 61 | Q9UKR0 | |
| GWTALHRSIFYGHID | 86 | Q9P2D0 | |
| NAALLAYHRWNGHTD | 476 | Q9UHG3 | |
| RIKIHFDGWSHGYDF | 546 | Q9Y468 | |
| HAAQRFLSRYGWSGV | 51 | Q8N119 | |
| GPHNRLYHFLLGAWS | 61 | Q96PD5 | |
| FFSGWVQHRRGSVHL | 166 | Q5VWM3 | |
| RHLGWNPDARYSEHF | 291 | Q9H1C3 | |
| HYAAARGHATWLSEL | 741 | Q8N8A2 | |
| RGDHYARNLLWFDFG | 201 | Q96RP7 | |
| HEYLGWHADCIRGTF | 96 | P0CG30 | |
| YLHLHWRTGATFCRV | 81 | Q9NQS5 | |
| DQYHLFRHGVAHGQW | 251 | Q9H7L2 | |
| YGWEFHDGLSFGRQH | 146 | Q13724 | |
| KEWLSFGHRFSHRGA | 1456 | O95248 | |
| HWELGQALRQRYHGF | 76 | P11117 | |
| GHYFRGHLGTLVFWS | 416 | Q9BXP8 | |
| YAHALLAGRGHDRWF | 436 | Q8TCG5 | |
| AAFHRYHWSRCSGQE | 431 | O15072 | |
| GDLWGHLHDRYGQLV | 116 | O75146 | |
| RVAKNQYGWHGRHSL | 201 | Q96AV8 | |
| FCWANIHSRAGREFH | 556 | Q7Z5Q1 | |
| HRGIHNSIGDYRWQL | 221 | P15924 | |
| HEYLGWHADCIRGTF | 96 | P0CG29 | |
| LGHSGLYACFHRDSW | 81 | P26992 | |
| QDLGWYHGNLTRHAA | 31 | Q9UN19 | |
| GLYHFCLYWNRHAGR | 86 | Q9Y653 | |
| WELRQKGSVHHDYRG | 286 | P05108 | |
| FHERSGNYLWHGHLR | 176 | O75072 | |
| SSRWEHLIYQFGGHH | 396 | Q96NU7 | |
| GYNARLNRHFHDLWK | 256 | Q9BQ90 | |
| REWEYSHRHGFRCQF | 726 | Q8WUQ7 | |
| YCWAAIHSRAGREFH | 696 | Q17RY0 | |
| YHSNLFRGQDAWDPH | 2346 | Q9NYQ7 | |
| GRGYWRRQLDHISAH | 476 | Q9NVP4 | |
| YRDGAWGAFRHFLLE | 1506 | P49327 | |
| RRHDYWLLAGIINHG | 1731 | Q14839 | |
| SPNLWGHEFRSHHDY | 121 | Q15768 | |
| SHPDQRAHFRGWGYR | 471 | O75807 | |
| HSLDGFRHQALWDRY | 336 | O43427 | |
| HRYHGRSAAVWSLGI | 216 | P11309 | |
| LHHGDRILWGNNHFF | 526 | Q9NQT8 | |
| TLQFSVWHHGRFGRN | 441 | Q96C24 | |
| WHYDRFGRNSFLGEV | 496 | Q8TDW5 | |
| YSGGLGRQFFHLHWH | 76 | P59536 | |
| NSWRQHREAAAYLHG | 286 | P21549 | |
| RFHARSLWTNHKRYG | 91 | Q9UN30 | |
| QFSSNGLHWHDYRDL | 2156 | A2VEC9 | |
| IHYHSLTGEADFNWR | 1766 | A0AVI2 | |
| LASWGHEYVRHLAGE | 151 | Q13200 | |
| AIGLYHACRGWGRHT | 41 | Q9Y289 | |
| GAHLNYHRSLISWGI | 271 | Q9H1U9 | |
| WVQFHLGINRHGLYS | 161 | Q96MK3 | |
| GQIGHNYLRDKWSHF | 496 | P48764 | |
| VSRAFYGWLAHCRHL | 496 | O43147 | |
| NRGWFCHLRNDSHYV | 566 | Q07837 | |
| AGAHRLWSHRSYRAK | 91 | Q86SK9 | |
| LGGALGLYHTARWHL | 66 | Q9H7Z7 | |
| WRIYSRGELHHFIDG | 136 | O75626 | |
| YAHQSGFHVDRRFGW | 71 | P41252 | |
| GAHLNYHRSLISWGI | 271 | Q3SY17 | |
| APFLAAFRADGRWHH | 196 | Q7Z7M1 | |
| RYNHWFDGLALLHSF | 46 | Q9HAY6 | |
| GTYRLIQFHFHWGSL | 86 | P00918 | |
| WFHNGTLLDRRAHGY | 326 | Q8IUL8 | |
| ASYHGNLAVLYHRWG | 686 | Q5T4D3 | |
| WIHARHLAGYRQQDA | 151 | A6NNY8 | |
| ANHYWSVDGLLNAHR | 176 | P38435 | |
| WDIVRHYGTHHFRGS | 136 | Q12788 | |
| GRYEIRSDHSLWIGH | 301 | Q96MS0 | |
| HTHFYDRLQDAGSRW | 196 | Q6P2H8 | |
| SYRGHLWLFRDAGTH | 111 | P40337 | |
| GWHGRHCNKRYEASL | 331 | Q9Y5W5 | |
| HNSRRGFFFSHVGWL | 171 | O00767 | |
| WRRGHFHGQSFYSTR | 71 | Q9UKJ0 | |
| WFSDHRYRCQRGIVH | 486 | Q9Y6X8 | |
| LALGAFLNHWRNRFH | 286 | Q969M1 | |
| DGRQRWGHRILHYSF | 336 | Q5GH77 | |
| FARRALWDAGLNYGH | 506 | O43895 | |
| WARHLIEHATGFYTG | 366 | Q658N2 | |
| ALSYLWFRADGHPGH | 51 | Q6UX68 | |
| YTRGRHHDQRGDFDW | 171 | Q93097 | |
| DGSSGRLQLWHHDYL | 66 | Q49AM3 | |
| RSRHWHEAKRAGYNL | 2731 | Q15911 | |
| RYVLYGNHRDSWVHG | 361 | Q9UQQ1 | |
| LALGAHSYWRQHGTL | 296 | Q14957 |